The global cancer monoclonal antibodies market is estimated to grow at a CAGR of 9.8% during the forecast period. The increasing prevalence of cancer and advances in biomedical research are pivotal factors encouraging market growth. As per the World Health Organization (WHO), in 2018, 18.1 million new cancer incidences were reported globally. Globally, in 2018, 43.8 million persons were suffering from cancer who were diagnosed within the last 5 years. Monoclonal antibodies served as one of the established therapeutic strategies for both solid tumors and hematologic malignancies. It is a type of immunotherapy that stimulates the immune system of cancer patients and works to find and attack cancer cells.
Get Free Sample link @ https://www.omrglobal.com/request-sample/cancer-monoclonal-antibodies-market
Some monoclonal antibodies that are utilized for cancer treatment are known as targeted therapy as it works by finding a specific target on a cancer cell and then attack those cells. However, some monoclonal antibodies also work as immunotherapy to make the immune system respond better which in turn, supports the body to more potentially find and attack cancer cells. Monoclonal antibodies are intravenously administered, and some monoclonal antibody drugs may be utilized along with hormone therapy and chemotherapy.
A full report of Global Cancer Monoclonal Antibodies Market available @ https://www.omrglobal.com/industry-reports/cancer-monoclonal-antibodies-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Cancer Monoclonal Antibodies Market by Type
- Naked
- Conjugated
- Others (Bispecific)
Global Cancer Monoclonal Antibodies Market by Application
- Breast Cancer
- Liver Cancer
- Blood Cancer
- Brain Cancer
- Colorectal Cancer
- Others
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- AbbVie, Inc.
- Amgen, Inc.
- AstraZeneca plc
- Bayer AG
- Biocon, Ltd.
- Bristol Myers Squibb Co.
- Daiichi Sankyo Company, Ltd.
- Eli Lilly and Co.
- Hoffmann-La Roche AG
- Genmab A/S
- GlaxoSmithKline plc
- Innate Pharma S.A.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Mylan N.V.
- Novartis AG
- Oncologie, Inc.
- Pfizer Inc.
- Spectrum Pharmaceuticals, Inc.
- Takeda Pharmaceutical Co., Ltd.
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global cancer monoclonal antibodies market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/cancer-monoclonal-antibodies-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
